FLORIO, PIER PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.872
EU - Europa 1.308
AS - Asia 328
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 5.518
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.868
RU - Federazione Russa 677
IE - Irlanda 290
IT - Italia 155
SE - Svezia 142
SG - Singapore 134
CN - Cina 108
HK - Hong Kong 50
IN - India 28
GB - Regno Unito 16
CH - Svizzera 8
DE - Germania 6
JO - Giordania 5
CA - Canada 4
CI - Costa d'Avorio 4
NL - Olanda 4
UA - Ucraina 4
EU - Europa 3
BO - Bolivia 2
FI - Finlandia 2
FR - Francia 2
TW - Taiwan 2
GR - Grecia 1
LT - Lituania 1
SC - Seychelles 1
TR - Turchia 1
Totale 5.518
Salva come PNG Salva come JPEG
Città #
Santa Clara 738
Fairfield 659
Seattle 297
Ashburn 294
Dublin 290
Woodbridge 287
Houston 240
Cambridge 217
Wilmington 194
Altamura 142
Lawrence 140
Singapore 111
Buffalo 71
Princeton 71
Boston 66
Chandler 62
Ann Arbor 56
Beijing 46
Mumbai 28
San Diego 26
Kent 18
Shanghai 17
Falls Church 14
Moscow 14
Medford 13
Norwalk 13
Andover 10
Hillsboro 10
Bern 8
Yubileyny 8
Redmond 5
Abidjan 4
Bremen 4
Toronto 4
Boardman 3
Coreno Ausonio 3
Guangzhou 3
Kilburn 3
Laurel 3
London 3
Shenzhen 3
Aversa 2
Chiswick 2
Cochabamba 2
Florence 2
Foshan 2
Helsinki 2
Jacksonville 2
Los Angeles 2
New Bedfont 2
Torrevecchia Pia 2
Arnsberg 1
Castelfranco Veneto 1
Cedar Knolls 1
Dongyang 1
Fremont 1
Heze 1
Hounslow 1
Islington 1
Izmir 1
Jiaxing 1
Jinan 1
Jinhua 1
Milan 1
Nantong 1
Padova 1
Paris 1
Philadelphia 1
Quanzhou 1
Rui'an 1
Shaoxing 1
Tiantai Chengguanzhen 1
Tongchuanshi 1
Trumbull 1
Vilnius 1
Wijchen 1
Wuhan 1
Xi'an 1
Totale 4.245
Salva come PNG Salva come JPEG
Nome #
Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor 121
Corticotropin-releasing factor-binding protein: Origins and possible functions 119
Abnormal umbilical artery Doppler waveforms and cord blood inhibin A and inhibin B levels 113
Corticotropin-releasing hormone facilitates early survival of discordant (bovine-to-rat) islet xenografts 111
Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery 110
Increased midtrimester amniotic fluid activin A: A risk factor for subsequent fetal death 109
Abruptio placentae and highest maternal serum activin a levels at mid-gestation: A two cases report 107
Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: Effect of prostaglandin administration 103
Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour 99
Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy 98
The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia 97
Changes in inhibins and activin secretion in healthy and pathological pregnancies 96
Activin A stimulates insulin secretion in cultured human pancreatic islets 96
Cervical ripening and induction of labor by prostaglandin E2: A comparison between intracervical gel and vaginal pessary 96
Maternal plasma calcitonin gene-related peptide levels do not change during labor and are not influenced by delivery route 94
Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women 93
Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitro 92
Stress and pregnancy: CRF as biochemical marker 91
Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases 91
Effect of acute corticotropin releasing factor on pituitary-adrenocortical responsiveness in elderly women and men 91
Corticotropin-releasing factor and its binding protein: Maternal serum levels in term and preterm deliveries 89
High serum follistatin levels in women with ovarian endometriosis 89
Hypertension in pregnancy: Changes in activin a maternal serum concentration 87
Human placenta, chorion, amnion and decidua express different variants of corticotropin-releasing factor receptor messenger RNA 87
High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension 87
Placental stress factors and human parturition 85
Local production and action of follistatin in human placenta 83
Maternal decidua and fetal membranes contain immunoreactive neuropeptide Y 83
Placental Neurokinin B mRNA Expression Increases at Preterm Labor 83
Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage 82
Human placental corticotropin-releasing factor (CRF) in the adaptive response to pregnancy 81
Corticotropin-releasing factor, urocortin and endothelian-1 stimulate activin A release from cultured human placental cells 81
Thickness of fetal membranes: A possible ultrasound marker for preterm delivery 81
Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation 80
High Levels of Intrauterine Corticotrophin-Releasing Hormone, Urocortin, Tryptase, and Interleukin-8 in Spontaneous Abortions 80
Activin A, corticotropin-releasing factor and prostaglandin F(2α) increase immunoreactive oxytocin release from cultured human placental cells 78
Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle 77
Prediction of successful induction of labor at term: Role of clinical history, digital examination, ultrasound assessment of the cervix, and fetal fibronectin assay 77
Activin A, inhibin A, inhibin B and parturition: Changes of maternal and cord serum levels according to the mode of delivery 75
High levels of serum allopregnanolone in women with premature ovarian failure 75
Secretory endometrium highly expresses urocortin messenger RNA and peptide: Possible role in the decidualization process 75
High fetal urocortin levels at term and preterm labor 75
Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol 74
Placental expression of substance P and vasoactive intestinal peptide: Evidence for a local effect on hormone release 73
Inhibins and activins in pregnancy 72
Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women 72
Cerebrospinal Fluid Activin A Measurement in Asphyxiated Full-Term Newborns Predicts Hypoxic Ischemic Encephalopathy 72
Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes 72
The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia 70
Expression and secretion of activin A: Possible physiological and clinical implications 67
Human placenta and fetal membranes express nerve growth factor mRNA and protein 66
Activin A and activin B measured in maternal serum, cord blood serum and amniotic fluid during human pregnancy 64
Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein 63
Pre-eclampsia with fetal growth restriction: Placental and serum activin A and inhibin A levels 63
Human placenta and fetal membranes express follistatin-related gene mRNA and protein 63
Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal pathological pregnancies 62
Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women 62
Mutational analysis of the inhibin alpha gene in preeclamptic women 62
Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy 61
Paracrine/autocrine control of female reproduction 56
null 54
Serum activin A levels in males and females during pubertal development 54
High levels of fetal membrane activin βA and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor 49
Stress und Frühgeburt Neuroendokriner Hintergrund von akutem und chronischem Stress als Auslöser für eine Frühgeburt 47
La miomectomia per via laparoscopica: Confronto tra elettrochirurgia e bisturi ad ultrasuoni 46
Human GnRH-secreting cultured neurons express activin βA subunit mRNA and secrete dimeric activin A 46
Postmenopause is associated with a decrease in serum inhibin A and inhibin B levels but not in activin A 45
The detection of anti-β2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester 45
Esteroides en el embarazo 43
Lack of gestation-related changes of urocortin gene expression in human placenta 42
Activins and related proteins in the establishment of pregnancy 41
Parturition in two pregnant women with Addison's disease: Changes of plasma corticotropin releasing factor levels 38
Fetal neural tube defects: Maternal serum and amniotic fluid activin A levels 36
Totale 5.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.195 0 0 0 0 234 206 188 179 183 96 76 33
2020/2021419 65 40 10 71 29 7 1 8 82 13 87 6
2021/2022545 20 77 61 9 16 11 43 20 12 17 110 149
2022/2023919 110 302 40 27 16 134 174 23 45 12 23 13
2023/2024210 9 22 75 5 19 30 10 7 4 0 20 9
2024/20251.817 167 247 122 387 894 0 0 0 0 0 0 0
Totale 5.597